Cargando…
Syn-Lethality: An Integrative Knowledge Base of Synthetic Lethality towards Discovery of Selective Anticancer Therapies
Synthetic lethality (SL) is a novel strategy for anticancer therapies, whereby mutations of two genes will kill a cell but mutation of a single gene will not. Therefore, a cancer-specific mutation combined with a drug-induced mutation, if they have SL interactions, will selectively kill cancer cells...
Autores principales: | Li, Xue-juan, Mishra, Shital K., Wu, Min, Zhang, Fan, Zheng, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016865/ https://www.ncbi.nlm.nih.gov/pubmed/24864230 http://dx.doi.org/10.1155/2014/196034 |
Ejemplares similares
-
SynLethDB: synthetic lethality database toward discovery of selective and sensitive anticancer drug targets
por: Guo, Jing, et al.
Publicado: (2016) -
SynLethDB 2.0: a web-based knowledge graph database on synthetic lethality for novel anticancer drug discovery
por: Wang, Jie, et al.
Publicado: (2022) -
Methodological approaches in application of synthetic lethality screening towards anticancer therapy
por: Canaani, D
Publicado: (2009) -
Development of Synthetic Lethality
Anticancer Therapeutics: Miniperspective
por: Fang, Bingliang
Publicado: (2014) -
Rapid
Inhibitor Discovery by Exploiting Synthetic
Lethality
por: Muscato, Jacob D., et al.
Publicado: (2022)